CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
35.52 0.14(0.40%) NAV as on 10 Jul 2026
6.35 % 1 M
15.93 % 1 Y
22.99 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.30

As on 31 Mar, 2026
age-icon Age :

7 yrs 0 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

1,010.54 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.64

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jun 30 ,2026
Others 2.15 %
Equity 97.85 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.09 %
Apollo Hospitals Enterprise Ltd.7.30 %
JB Chemicals & Pharmaceuticals...4.71 %
Torrent Pharmaceuticals Ltd.4.68 %
Aurobindo Pharma Ltd.4.55 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.20
Hospital & Healthcare Services20.04
Business Support1.77
Chemicals0.85
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)18.2216.3626.4529.3930.19
Net Assets(Rs Crores) (as on 31-Mar-2026) 515.33 428.44 699.55 814.95 858.87
Scheme Returns(%)(Absolute)12.40-10.2661.3810.034.21
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7570/7611/9032/10220/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity35.520.14(0.40%)NAV As on 10 Jul, 202610-Jul-2019Inception Date1,010.54AUM In Cr.15.93%1Y22.99%3Y13.27%5Y19.83%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity43.560.35(0.81%)NAV As on 10 Jul, 202613-Jul-2018Inception Date6,624.58AUM In Cr.9.67%1Y25.62%3Y16.00%5Y20.20%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity498.691.94(0.39%)NAV As on 10 Jul, 202614-Jul-1999Inception Date4,997.72AUM In Cr.15.25%1Y24.31%3Y16.46%5Y16.28%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity44.320.12(0.28%)NAV As on 10 Jul, 202602-Jul-2018Inception Date3,252.55AUM In Cr.15.51%1Y23.95%3Y14.24%5Y20.38%Since Inception